Anemia is defined by a decrease in hemoglobin concentration, with a consequent decrease in hematocrit. It is the most common medical disorder in pregnancy. The 2 most common causes of anemia are iron deficiency and acute blood loss at delivery [1]. Depending on the severity of the blood loss, anemic postpartum patients can be at increased risk for morbidity and even mortality [2], and anemia du...

Background: Postpartum anemia can develop after delivery because of unforeseen medical problems during and after delivery which could complicate a mother’s ability to properly care for her newborn child. The current treatment for postpartum anemia is oral iron supplementation but this treatment has been associated with several gastrointestinal side effects. Alternative treatments include blood ...

pharmacological basis of therapeutics, 9th ed. New York: McGraw-Hill, 1996:1311–40. 7. Henderson PA, Hillman RS. Characteristics of iron dextran utilization in man. Blood 1969;34:357–75. 8. American Regent Laboratories. Dexferrum, iron dextran injection, USP. Package insert. Shirley, NY: American Regent Laboratories, 1996. 9. Nissenson AR, Lindsay RM, Swan S, Seligman PA, Strobos J. Sodium ferr...

BACKGROUND Iron deficiency anemia (IDA) is a significant problem worldwide particularly in women. The aim of the study was to evaluate the effectiveness and safety of intravenous ferric carboxymaltose (FCM) in comparison to iron sucrose (IS) in women with IDA. METHOD Two hundred patients at Department of Obstetrics and Gynaecology, Sher-i-Kashmir Institute of Medical Sciences Medical College ...

Oral iron supplementation is usually the first choice for the treatment of iron deficiency anemia (IDA) because of its effectiveness and low cost. But unfortunately in many iron deficient conditions, oral iron is a less than the ideal treatment mainly because of adverse events related to the gastrointestinal tract as well as the long course required to treat anemia and replenish body iron store...

OBJECTIVES This study was undertaken to assess the hematologic, clinical, and biochemical response to intravenous iron in patients with chronic heart failure (CHF) and anemia. BACKGROUND Anemia is common in patients with CHF and is associated with higher morbidity and mortality. The combination of erythropoietin (EPO) and iron increases hemoglobin (Hb) and improves symptoms and exercise capac...